American CRO Charles River Reacts To Global Crisis, Falling Profits With Plans To Close One U.S. Facility While Expanding In China

BEIJING - Hit in sucession by the West's economic meltdown, foreign exchange losses and declining business from American pharmaceutical and biotech outfits, Charles River Laboratories is responding with plans to close one U.S. testing center and to expand operations in still-rising China

More from Archive

More from Scrip